KIMBERLY SHERRILL: Open Payments
NPI 1760452734 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 10 payments from 8 companies in 2025. Trend: 2023 $47 · 2024 $156 · 2025 $371
Food & beverage: $353Education: $18
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $205 |
| AKEBIA THERAPEUTICS INC | 1 | $87 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 2 | $2 |
Products named: XPHOZAH 30 MG, Vafseo, IBSRELA, LOKELMA, JARDIANCE, RAYALDEE, TAVNEOS, VELPHORO.
Industry payments across LA — which companies pay providers there.
